Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | NAAA | Q02083 | 3/20 | 0.72 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28427008 | 1.00 | HTT (0.75) | HTTTSHRNAAAHPGDALDH1A1 | |
| SCHEMBL28422552 | 1.00 | HTT (0.75) | HTTTSHRNAAAHPGDALDH1A1 | |
| SCHEMBL8963414 | 1.00 | HTT (0.75) | HTTTSHRNAAAHPGDALDH1A1 | |
| SCHEMBL23610299 | 1.00 | HTT (0.75) | HTTTSHRNAAAHPGDALDH1A1 | |
| SCHEMBL2638598 | 1.00 | HTT (0.75) | HTTTSHRNAAAHPGDALDH1A1 | |
| SCHEMBL23610316 | 1.00 | HTT (0.75) | HTTTSHRNAAAHPGDALDH1A1 | |
| SCHEMBL11089466 | 1.00 | HTT (0.75) | HTTTSHRNAAAHPGDALDH1A1 | |
| SCHEMBL14483849 | 1.00 | HTT (0.75) | HTTTSHRNAAAHPGDALDH1A1 | |
| SCHEMBL8337568 | 1.00 | HTT (0.75) | HTTTSHRNAAAHPGDALDH1A1 | |
| SCHEMBL29863141 | 1.00 | HTT (0.75) | HTTTSHRNAAAHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4650988-B2 | — | — | 2011-03-16 | — | — | JP | claimed |
| EP-1226113-B1 | ESTERS COMPRISING A SECONDARY CARBAMOYL FUNCTION AND THEIR USE AS ODORANT ALCOHOL PRECURSORS | FIRMENICH & CIE (CH) | 2005-11-09 | — | — | EP | claimed |
| US-6677297-B2 | PERFUMES FOR TEXTILES; PROLONGED DIFFUSION | FIRMENICH SA (CH) | 2004-01-13 | — | — | US | claimed |
| JP-2003520203-A | — | — | 2003-07-02 | — | — | JP | claimed |
| US-20020144360-A1 | Esters comprising a secondary carbamoyl function and their use as odorant alcohol precursors | FIRMENICH SA (CH) | 2002-10-10 | — | — | US | claimed |
| EP-1226113-A1 | ESTERS COMPRISING A SECONDARY CARBAMOYL FUNCTION AND THEIR USE AS ODORANT ALCOHOL PRECURSORS | Firmenich S.A. (CH) | 2002-07-31 | — | — | EP | claimed |
| WO-2001028980-A1 | ESTERS COMPRISING A SECONDARY CARBAMOYL FUNCTION AND THEIR USE AS ODORANT ALCOHOL PRECURSORS | FIRMENICH S.A. (CH) | 2001-04-26 | — | — | WO | claimed |
| EP-0208617-B1 | CONTROLLED DRUG DEVICE AND PROCESS FOR CATALYSING THE EROSION OF AN ACID LABILE POLYMER | MERCK & CO. INC. (US) | 1990-09-26 | — | — | EP | claimed |
| US-4780319-A | DRUG DELIVERY USING POLYORTHOESTERS COATINGS | MERCK & CO., INC. (US) | 1988-10-25 | — | — | US | claimed |
| EP-0208617-A1 | Controlled drug device and process for catalysing the erosion of an acid labile polymer | MERCK & CO. INC. (US) | 1987-01-14 | — | — | EP | claimed |
| CN-111333532-B | N-alkyl phthalic diamide acid derivative and synthetic method and application thereof | 江苏顶塑实业有限公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-111333532-A | N-alkyl phthalic diamide acid derivative and synthetic method and application thereof | 江苏顶塑实业有限公司 | 2020-06-26 | — | — | CN | disclosed |
| US-9182689-B2 | Electrostatic image developing toner, electrostatic image developer, toner cartridge, process cartridge, image forming method, and image forming apparatus | FUJI XEROX CO., LTD. (JP) | 2015-11-10 | — | — | US | disclosed |
| US-8546058-B2 | Electrostatic latent image developing toner, electrostatic latent image developer, image forming apparatus, and apparatus for manufacturing electrostatic latent image developing toner | FUJI XEROX CO., LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-1909143-B1 | Electrostatic latent image developing toner, method of producing the same, electrostatic latent image developer, and image forming apparatus | FUJI XEROX CO LTD (JP) | 2013-09-04 | — | — | EP | disclosed |
| US-4675422-A | ALUMINUM COATINGS | STEPAN COMPANY (US) | 1987-06-23 | — | — | US | disclosed |
| EP-0220934-A2 | Aluminium carboxylates | STEPAN COMPANY (US) | 1987-05-06 | — | — | EP | disclosed |
| EP-0208617-A1 | Controlled drug device and process for catalysing the erosion of an acid labile polymer | MERCK & CO. INC. (US) | 1987-01-14 | — | — | EP | disclosed |
| US-4188236-A | ORGANIC PIGMENT, ROSIN, SORBITAN ESTER, CARRIER, DUSTLESS | CIBA-GEIGY CORPORATION (US) | 1980-02-12 | — | — | US | disclosed |
| US-4175979-A | MIXING AN AQUEOUS PROTECTIVE COLLOID, WATER INSOLUBLE CARRIER, AN AQUEOUS DISPERSION OF PIGMENT OR WATER INSOLUBLE DYESTUFF AND SEPARATING | CIBA-GEIGY CORPORATION (US) | 1979-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020144360-A1 | Esters comprising a secondary carbamoyl function and their use as odorant alcohol precursors | ADH1C, ADH1A, CBR1 | HTT 4619/4885TSHR 2410/4885NAAA 2383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.